Scemblix and Malaise - a phase IV clinical study of FDA data

Summary:

Malaise is reported as a side effect among people who take Scemblix (asciminib hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Pantoprazole, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Malaise when taking Scemblix. It is created by eHealthMe based on reports of 948 people who have side effects when taking Scemblix from the FDA, and is updated regularly.

What is Scemblix?

Scemblix has active ingredients of asciminib hydrochloride. eHealthMe is studying from 948 Scemblix users. Check the latest studies of Scemblix.

What is Malaise?

Malaise (a feeling of general discomfort or uneasiness) is found to be associated with 3,491 drugs and 5,128 conditions by eHealthMe. Check the latest studies of Malaise.

On Aug, 11, 2026

948 people reported to have side effects when taking Scemblix.
Among them, 23 people (2.43%) have Malaise.

Among these 23 people:

How long have people been on Scemblix when they have Malaise? *

What is the gender of people who have Malaise when taking Scemblix? *

female: 45 %
male: 55 %

What is the age of people who have Malaise when taking Scemblix? *

What are other drugs people take besides Scemblix? *

What are other side effects people have besides Malaise? *

Nausea (feeling of having an urge to vomit): 6 people, 26.09%
Headache (pain in head): 4 people, 17.39%
Electrocardiogram Qt Prolonged: 3 people, 13.04%
Dizziness: 3 people, 13.04%
Renal Impairment (severely reduced kidney function): 3 people, 13.04%
Joint Pain: 2 people, 8.70%
Fatigue (feeling of tiredness): 2 people, 8.70%
Infection: 2 people, 8.70%
Weakness: 2 people, 8.70%
Neuropathy Peripheral (surface nerve damage): 2 people, 8.70%

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 17 people, 73.91%
Type 2 Diabetes: 2 people, 8.70%
Intraocular Pressure Increased: 2 people, 8.70%
High Blood Pressure: 2 people, 8.70%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 8.70%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 8.70%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 1 person, 4.35%
Nausea (feeling of having an urge to vomit): 1 person, 4.35%
Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 4.35%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Scemblix and have Malaise?

- Check whether Malaise is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Scemblix:

Scemblix (948 reports)

Malaise treatments and more:

Malaise (529,933 reports)

Browse all side effects of Scemblix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Malaise:

Malaise (3,491 drugs)

Browse all the conditions that are associated with Malaise:

Malaise (5,128 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on asciminib hydrochloride (the active ingredients of Scemblix) and Scemblix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.